Its primary action is to promote fat breakdown and reduce fat storage rather than alter appetite, nutrient absorption, or gastrointestinal function
In the case of very severe uptake disorders, a lifelong maintenance therapy with injections may be necessary if absorption through the intestine is no longer possible
Why this matters beyond the pill itself: Adherence has always been the silent challenge in obesity pharmacotherapy
Below GLP-1s, below approved oral pharmacotherapy, below surgery for appropriate candidates and beside, not instead of, diet and exercise
[2] Neurogenic bladder can cause urinary retention and cause symptoms similar to those of BPH
When chronic illness disrupts these pathways, the resulting systemic dysfunction can be debilitating